JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today the filing of its 2007 income statement, balance sheet, cash flow statement and statement of changes in shareholders’ equity, included in its 2007 Form 20-F previously filed with the SEC on February 29, 2008, in eXtensible Business Reporting Language (“XBRL”). This voluntary filing, Teva’s first under the SEC’s XBRL program, is designed to enhance Teva’s communications with the investment community, allowing shareholders and analysts to more easily review and analyze the Company’s financial information.
